Capital Group Companies Inc Form 8.3 - Sanofi SA (4218I)

TIDM0A2V

RNS Number : 4218I

Capital Group Companies Inc

02 December 2022

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

 
1.         KEY INFORMATION 
 
 Name of person dealing                            The Capital Group Companies, Inc. 
 Company dealt in                                  Sanofi 
                                                  ----------------------------------------- 
 Class of relevant security to which               Ordinary Shares (FR0000120578) 
  the 
  dealings being disclosed relate 
                                                  ----------------------------------------- 
 Date of dealing                                   01 December 2022 
                                                  ----------------------------------------- 
 
2.         INTERESTS AND SHORT POSITIONS 
 
(a)        Interests and short positions (following dealing) in the class of 
            relevant security 
            dealt in 
 
                                                 Long                        Short 
                                           Number           (%)       Number         (%) 
                                    -------------------  --------  ------------  ---------- 
 (1)   Relevant securities           4,862,186 shares      0.38 % 
                                    -------------------  --------  ------------  ---------- 
 (2)   Derivatives (other than 
        options): 
----  ----------------------------  -------------------  --------  ------------  ---------- 
 (3)   Options and agreements 
        to purchase/sell: 
----  ----------------------------  -------------------  --------  ------------  ---------- 
       Total                         4,862,186 shares      0.38 % 
----  ----------------------------  -------------------  --------  ------------  ---------- 
 
(b)        Interests and short positions in relevant securities of the company, 
            other than the 
            class dealt in 
 
 
 Class of relevant security:                     Long                        Short 
                                           Number           (%)       Number         (%) 
                                    -------------------  --------  ------------  ---------- 
 (1)   Relevant securities 
----  ----------------------------  -------------------  --------  ------------  ---------- 
 (2)   Derivatives (other than 
        options): 
----  ----------------------------  -------------------  --------  ------------  ---------- 
 (3)   Options and agreements 
        to purchase/sell: 
----  ----------------------------  -------------------  --------  ------------  ---------- 
       Total 
----  ----------------------------  -------------------  --------  ------------  ---------- 
 
 
 
3.      DEALINGS 
 
(a)     Purchases and sales 
 
                  Purchase/sale                               Number of relevant                    Price per unit 
                                                                  securities 
 Purchase                                          2,387 shares                               87.4607 - EUR 
                                                  -----------------------------------------  ---------------------------- 
 Purchase                                          67 shares                                  87.4800 - EUR 
                                                  -----------------------------------------  ---------------------------- 
 
(b)     Derivatives transactions (other than options transactions) 
 
          Product name                 Nature of transaction              Number of relevant            Price per unit 
             e.g. CFD                                                         securities 
 
 
(c)     Options transactions in respect of existing relevant securities 
 
(i)     Writing, selling, purchasing or varying 
 
   Product name     Writing,       Number of            Exercise        Type,                 Expiry        Option money 
     e.g. call       purchasing,    securities           price           e.g. American,        date          paid/ received 
      option         selling,       to which                             European                            per unit 
                     varying        the option                           etc. 
                     etc.           relates 
 
 
(ii)    Exercising 
 
 Product name                      Number of securities                               Exercise price per unit 
  e.g. call option 
 
 
(d)     Other dealings (including subscribing for new securities) 
 
 Nature of transaction             Details                                            Price per unit (if applicable) 
 
 
 
 
4.        OTHER INFORMATION 
 
Agreements, arrangements or understandings relating to options or derivatives 
 
 Full details of any agreement, arrangement or understanding between the 
  person disclosing and any other person relating to the voting rights of 
  any relevant securities under any option referred to on this form or relating 
  to the voting rights or future acquisition or disposal of any relevant 
  securities to which any derivative referred to on this form is referenced. 
  If none, this should be stated. 
 None 
 
 Is a Supplemental Form 8 attached?                   NO 
 
 Date of disclosure                                   02 December 2022 
 Contact name                                         Torrence M. Frame 
                                                     -------------------------------- 
 Telephone number                                     213 615 0469 
                                                     -------------------------------- 
 If a connected EFM, name of offeree/offeror 
  with which connected 
                                                     -------------------------------- 
 If a connected EFM, state nature of connection 
                                                     -------------------------------- 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEMZMGZLZKGZZG

(END) Dow Jones Newswires

December 02, 2022 04:16 ET (09:16 GMT)